Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Department of Medicine, University of Cambridge, Cambridge, UK.
J Pathol. 2019 Nov;249(3):356-367. doi: 10.1002/path.5322. Epub 2019 Aug 27.
Pulmonary arterial hypertension (PAH) is characterised by an increase in mean pulmonary arterial pressure which almost invariably leads to right heart failure and premature death. More than 70% of familial PAH and 20% of idiopathic PAH patients carry heterozygous mutations in the bone morphogenetic protein (BMP) type 2 receptor (BMPR2). However, the incomplete penetrance of BMPR2 mutations suggests that other genetic and environmental factors contribute to the disease. In the current study, we investigate the contribution of autophagy in the degradation of BMPR2 in pulmonary vascular cells. We demonstrate that endogenous BMPR2 is degraded through the lysosome in primary human pulmonary artery endothelial (PAECs) and smooth muscle cells (PASMCs): two cell types that play a key role in the pathology of the disease. By means of an elegant HaloTag system, we show that a block in lysosomal degradation leads to increased levels of BMPR2 at the plasma membrane. In addition, pharmacological or genetic manipulations of autophagy allow us to conclude that autophagy activation contributes to BMPR2 degradation. It has to be further investigated whether the role of autophagy in the degradation of BMPR2 is direct or through the modulation of the endocytic pathway. Interestingly, using an iPSC-derived endothelial cell model, our findings indicate that BMPR2 heterozygosity alone is sufficient to cause an increased autophagic flux. Besides BMPR2 heterozygosity, pro-inflammatory cytokines also contribute to an augmented autophagy in lung vascular cells. Furthermore, we demonstrate an increase in microtubule-associated protein 1 light chain 3 beta (MAP1LC3B) levels in lung sections from PAH induced in rats. Accordingly, pulmonary microvascular endothelial cells (MVECs) from end-stage idiopathic PAH patients present an elevated autophagic flux. Our findings support a model in which an increased autophagic flux in PAH patients contributes to a greater decrease in BMPR2 levels. Altogether, this study sheds light on the basic mechanisms of BMPR2 degradation and highlights a crucial role for autophagy in PAH. © 2019 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
肺动脉高压(PAH)的特征是平均肺动脉压升高,几乎总是导致右心衰竭和过早死亡。超过 70%的家族性 PAH 和 20%的特发性 PAH 患者携带骨形态发生蛋白(BMP)型 2 受体(BMPR2)的杂合突变。然而,BMPR2 突变的不完全外显率表明,其他遗传和环境因素也与该疾病有关。在本研究中,我们研究了自噬在肺血管细胞中 BMPR2 降解中的作用。我们证明,内源性 BMPR2 通过溶酶体在原代人肺动脉内皮细胞(PAECs)和肺动脉平滑肌细胞(PASMCs)中降解:这两种细胞在疾病的病理学中起着关键作用。通过一种精致的 HaloTag 系统,我们表明溶酶体降解的阻断会导致质膜上 BMPR2 水平的增加。此外,自噬的药理学或遗传学操作使我们能够得出结论,自噬的激活有助于 BMPR2 的降解。尚需进一步研究自噬在 BMPR2 降解中的作用是直接的还是通过内吞途径的调节。有趣的是,使用 iPSC 衍生的内皮细胞模型,我们的发现表明,BMPR2 杂合性本身足以引起自噬通量的增加。除了 BMPR2 杂合性,促炎细胞因子也有助于肺血管细胞中自噬的增加。此外,我们证明在大鼠诱导的 PAH 肺组织切片中微管相关蛋白 1 轻链 3β(MAP1LC3B)水平增加。因此,特发性终末期 PAH 患者的肺微血管内皮细胞(MVECs)表现出升高的自噬通量。我们的研究结果支持这样一种模型,即在 PAH 患者中,自噬通量的增加导致 BMPR2 水平的更大下降。总之,这项研究阐明了 BMPR2 降解的基本机制,并强调了自噬在 PAH 中的关键作用。